OBERWEIS ASSET MANAGEMENT INC/ - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 186 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
OBERWEIS ASSET MANAGEMENT INC/ ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,915,980
-69.4%
33,000
-79.1%
0.20%
-88.8%
Q3 2015$6,252,000
-30.4%
158,235
+9.3%
1.82%
-23.3%
Q2 2015$8,984,000
+98.0%
144,785
+99.6%
2.38%
+86.6%
Q1 2015$4,537,000
+379.1%
72,535
+331.8%
1.27%
+350.2%
Q4 2014$947,00016,8000.28%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 272,801$15,838,8267.50%
Global Alpha Capital Management Ltd. 525,528$30,512,1563.06%
Rubric Capital Management LP 847,011$49,177,4591.84%
Ranger Investment Management 426,848$24,782,7951.64%
Parkman Healthcare Partners LLC 111,802$6,491,2241.19%
MARATHON CAPITAL MANAGEMENT 71,670$4,161,1601.05%
Mesirow Financial Investment Management, Inc. 3,862$224,2280.98%
Deep Track Capital, LP 400,000$23,224,0000.90%
1492 Capital Management LLC 18,178$1,055,4150.68%
Phocas Financial Corp. 75,213$4,367,0000.64%
View complete list of ANI PHARMACEUTICALS INC shareholders